The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor by Tatiana, Lopatina et al.
Volume 4 • Issue 10 • 1000245
J Stem Cell Res Ther
ISSN: 2157-7633 JSCRT, an open access journal 
Open AccessResearch Article
Stem Cell
Research & Therapy
Lopatina et al., J Stem Cell Res Ther 2014, 4:10
http://dx.doi.org/10.4172/2157-7633.1000245
The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived 
Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor
Tatiana Lopatina1, Aurora Mazzeo1, Stefania Bruno2, Ciro Tetta3, Natalia Kalinina4, Renato Romagnoli5, Mauro Salizzoni5, Massimo Porta1 
and Giovanni Camussi1*
1Department of Medical Sciences, University of Torino, Torino, Italy
2Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
3EMEA LA Medical Board, Fresenius Medical Care, Bad Homburg, Germany
4Department of Fundamental Medicine, Lomonosov Moscow State University, Russia
5Liver Transplantation Center, University of Torino, Torino, Italy
*Corresponding author: Dr. Giovanni Camussi, Dipartimento di Medicina Interna, 
Ospedale Maggiore S. Giovanni Battista, Corso Dogliotti 14, 10126 Torino, Italy, 
Tel: +39-011-6336708; Fax: +39-011-6631184; E-mail: giovanni.camussi@unito.it
Received September 08, 2014; Accepted November 17, 2014; Published 
November 19, 2014
Citation: Lopatina T, Mazzeo A, Bruno S, Tetta C, Kalinina N, et al. (2014) The 
Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular 
Vesicles is modulated by Basic Fibroblast Growth Factor. J Stem Cell Res Ther 4: 
245. doi:10.4172/2157-7633.1000245
Copyright: © 2014 Lopatina T, et al. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.
Keywords: Adipose mesenchymal stem cells; Extracellular vesicles; 
bFGF; Angiogenesis
Introduction
Adipose tissue is constantly growing in the adult organism and is 
one of the more actively remodelled tissues [1,2]. This tissue is well 
vascularized. Adipose mesenchymal stem cells (ASCs) are located 
in the vessel walls [3,4] and may regulate angiogenesis and repair 
processes [4,5]. Being easily available by liposuction, ASCs are one 
of the most promising sources of adult stem cells for cell therapy. 
However, stem cell employment may be limited by tumorigenesis or 
maldifferentiation [6]. Recent studies indicated that stem cells enhance 
angiogenesis and regenerative processes by producing several bioactive 
molecules (growth factors, cytokines, etc.) [7-10]. The beneficial effect 
of conditioned medium derived from mesenchymal stem cells supports 
this paracrine view of stem cells action [11,12]. Previous studies 
indicated that many of the regenerative functions of adult stem cells 
are mediated by the release of extracellular vesicles (EVs) [13]. EVs are 
membrane vesicles in size of nanometers that may act as an intercellular 
mediator of cell-to-cell communication and, depending of the cell of 
origin, EVs are able to regulate migration, proliferation, differentiation, 
angiogenesis, inflammation, and other biological processes [14-20]. All 
types of EVs carry adhesion molecules and receptors on their surface, 
which are necessary for their correct contact with the recipient cells 
and for their entry into them. EVs can fuse with the plasma membrane 
of target cells releasing their contents inside. EVs transfer not only 
proteins but also nucleic acids. This leads to activation of defined 
signalling pathways in the recipient cells. These mechanisms have been 
described in several regenerative processes, such as angiogenesis [20], 
liver [21] and kidney repair [22,23]. 
We recently reported that EVs derived from PDGF stimulated 
ASCs enhance their angiogenic potential, suggesting that soluble 
factors acting on ASCs may modulate secretion and function of 
derived EVs [13]. In the present study we evaluated whether the basic 
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Objective: The aim of the present study was to investigate the effects of basic fibroblast growth factor (bFGF) 
on the angiogenic properties of extracellular vesicles (EVs) secreted by adipose-derived mesenchymal stem cells 
(ASCs) in culture. 
Methods: We isolated EVs from ASC (ASC-EVs) cultured with bFGF (FGF-EVs) or without bFGF (b-EVs). 
We compared the EV angiogenic action on human microvascular endothelial cells (HMEC) in vitro by capillary-
like structure formation assay and in vivo by subcutaneous injection of HMEC-containing Matrigel in SCID mice. 
We analysed micro-RNA composition of EVs by PCR array and we selected two mi-RNAs changed after bFGF 
stimulation: miR-223 and miR-21. We transfected HMEC with short antisense anti-miR-223 or with mimic miR-
21 to compensate the action of EVs. 
Results: In vitro, the total length and the number of branches of vessel-like structures formed by FGF-EV-
stimulated HMEC were significantly reduced in respect to b-EV stimulation and the structures were significantly 
larger than after b-EV stimulation. In vivo, vessels formed by FGF-EV-stimulated HMEC were significantly lower 
in number in respect to those formed by b-EV-stimulated HMEC, but they were significantly larger in size and 
contained cells positive for mouse smooth muscle actin. We found that bFGF led to molecular changes in ASC-
EVs characterized by decreased expression of angiogenic factors. Moreover, bFGF stimulation up-regulated the 
expression of the anti-angiogenic miR-223 and decreased the level of pro-angiogenic miR-21. The effects of FGF-
EVs were antagonized by the inhibition of miR-233 and by the miR-21 mimic 
Conclusions: The results indicate that culture conditions may modify the pro-angiogenic activity of ASC-
derived EVs, changing their protein and RNA contents. In particular, bFGF induces production of EVs that 
stimulate vessel stabilization rather than an increase in vessel number.
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fibroblast growth factor (bFGF) modify the number and function of 
EVs released from ASCs. bFGF is the first pro-angiogenic molecule 
identified [24] and it is capable to stimulate survival, proliferation, 
migration and differentiation of endothelial cells [25]. Moreover, bFGF 
plays an essential role in expansion, osteogenic and chondrogenic 
differentiation of mesenchymal stem cells [26]. Based on these 
considerations, we expected that bFGF would increase the angiogenic 
characteristics of ASC-derived EVs. Unexpectedly, we found that bFGF 
instead decreased the angiogenic properties of ASC-EVs by modifying 
their content of pro- and anti-angiogenic factors.
Methods
Cell cultivation and EV collection
ASCs and human microvascular endothelial cells (HMEC) were 
purchased from Lonza. ASCs were cultured in MSCGM™ Mesenchymal 
Stem Cell Growth Medium (Lonza) containing, 1% antibiotic–
antimycotic (HyClone) at 37°C in 5% CO2 incubator. Moreover, ASCs 
were also obtained with informed consent from subcutaneous tissue 
of non-tumor patients undergoing surgery according to a protocol 
approved by Ethic committee of the Città della Salute e della Scienza 
di Torino (Permit number 0012175). ASCs were isolated by enzyme 
treatment as described previously [9]. For the experiments, ASCs of 
the 4-6 passages were used. HMEC were cultured in EBM-2 growth 
medium (Lonza) supplemented with a cocktail of angiogenic factors 
(SingleQuots; Lonza) according to the instructions of the manufacturer.
For EV collection from ASCs, cells were cultured in DMEM without 
FBS for 24 hours. Then the medium was replaced with fresh DMEM 
FBS-free (basal condition, b-EVs) or with DMEM FBS-free containing 
20 ng/ml bFGF (FGF-EVs). Mesenchymal surface markers of ASCs 
did not change after FBS deprivation, as well as, after stimulation with 
bFGF (data not shown). Supernatants of ASCs were first centrifuged at 
3k and 10k g to remove debris, apoptotic bodies, large vesicles and then 
submitted to ultracentrifugation for 3 hours at 4°C at 100k g (Beckman 
Coulter Optima L-90K ultracentrifuge; Beckman Coulter, Fullerton, 
CA) as previously described [13]. The pellet was re-suspended in 
DMEM FBS-free. 
Analysis of EV quantity and size distribution was performed using 
NanoSight LM10 (NanoSight Ltd, Minton Park UK). Using a laser 
light source the particles in the sample are illuminated, the scattered 
light is captured by the camera and analysed by Nanoparticle Tracking 
Analysis (NTA). Using NTA, the particles are automatically tracked 
and sized based on Brownian motion and the diffusion coefficient (Dt). 
Results are displayed as a frequency size distribution graph and output 
to a spreadsheet. 
To trace EVs by fluorescent microscopy and to prove that EVs 
are membrane vesicles and not protein aggregates, they were labelled 
with the red fluorescent aliphatic chromophore intercalating into lipid 
bilayers PKH26 dye (Sigma-Aldrich). After labelling, EVs were washed 
by ultracentrifugation at 100k g and re-suspended in DMEM. 
HMEC transfection
For depletion of miR21 and miR223 in HMEC, we transfected the 
cells using HiPerfect Transfection Reagent (Qiagen) according to the 
instructions of the manufacturer. Mimic miR-21 (Sigma) and anti-
miR-223 (Qiagen) were used for transfection. AllStars Negative Control 
siRNA Alexa 488 (Qiagen, 100 nM) was used as negative control.
For all in vitro experiments we decided to use concentration of EVs 
equal to their concentration in ASC conditioned media, when ASCs 
achieved confluence: this concentration was 10×1010 ( ± 1×103) EVs/
ml [13]. 
Secreted protein antibody array
Purified EVs were lysed in 1 ml of 2x Cell Lysis Buffer (RayBiotech, 
Inc, GA), and aliquots (1000 mg protein) were added to the “RayBio 
Biotin Label-based Human Antibody Array I” (RayBiotech, Inc, GA) 
and processed according to the instructions of the manufacturer. The 
array provides detection of 507 secreted proteins. The analysis was 
repeated with three different samples of b-EVs and FGF-EVs. Only 
proteins detected in all three experiments were mentioned as evidently 
detected. The biotin-conjugated antibodies on each membrane served 
as positive controls. 
Immunoblotting
Protein samples were separated by 4% to 15% gradient sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS PAGE) and 
subjected to immunoblotting with antibodies to TGFb-1, IGFR1, 
CD29, Pax6, GAPDH, VEGFA (Santa Cruz). The protein bands were 
visualized with an enhanced chemiluminescence (ECL) detection kit 
and ChemiDoc™ XRS+ System (BioRad). Ten µg/well of cell lysates 
were loaded. 
RNA extraction
Total RNA was isolated from different EVs using the mirVana 
RNA isolation kit (Ambion) according to the manufacturer's protocol. 
Since the intact 18S and 28S rRNAs were hardly detectable in the EVs, 
RNA was quantified spectrophotometrically (Nanodrop ND-1000, 
Wilmington DE).
miRNA profiling by quantitative real-time PCR
miRNA expression levels were analysed using the Applied 
Biosystems TaqMan® MicroRNA Assay Human Panel Early Access kit 
(Applied Biosystems, Foster City, CA) to profile 365 mature miRNAs 
by qRT-PCR. The kit used gene-specific stem-loop reverse transcription 
primers and TaqMan probes to detect mature miRNA transcripts 
in a 2-step real-time reverse-transcription PCR assay. Briefly, single 
stranded cDNA was generated from total RNA sample (80 ng) by 
reverse transcription using a mixture of looped primers (Multiplex 
RT kit, Applied Biosystems) following manufacturer's protocol. The 
RT reactions were then diluted and mixed with a Taqman universal 
master Mix (Applied) in a ratio 1:1, loaded in the TaqMan micro-
fluid card and qRT-PCR experiments were performed. All reactions 
were performed using an Applied Biosystems 7900HT real-time PCR 
instrument equipped with a 384 well reaction plate. Raw Ct values were 
calculated using the SDS software version 2.3 using automatic baseline 
and threshold. We have analyzed miR expression in 2 samples of b-EVs 
and 2 samples of FGF-EVs. Only miRs that were presented in both 
equal samples were considered as evidently expressed. 
We analyzed 2 different samples of b-EVs and 2 of FGF-EVs. All 
microRNAs that were amplified after 35 cycles of PCR were classified 
as non-expressed. Only microRNA that were detected or not in both 
equal samples were taken under consideration. MicroRNAs that were 
detected in all samples but with difference in threshold cycle (Ct) more 
than 1.5 were classified as microRNA with changed expression.
qRT-PCR was used to confirm some miRNAs screened by 
microarray analysis. Briefly, 200 ng of input RNA from all samples 
were reverse transcribed with the miScript Reverse Transcription Kit 
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and the cDNA was then used to detect and quantify miRNAs of interest 
by qRT-PCR using the miScript SYBR Green PCR Kit (all from Qiagen, 
Valencia, CA, USA). All samples were run in triplicate using 3 ng of 
cDNA for each reaction as described by the manufacturer's protocol 
(Qiagen). miRNA specific primers to hsa-miR-221, -99a, -21, -31, 
and -223, were used in separate reactions. The snoRNAs, RNU48 and 
RNU44 were used as positive controls. Negative controls using 10 µl 
of water in place of the RNA were performed alongside each reaction. 
qRT-PCR was performed using a 48- well StepOne™ Real Time System 
(Applied Biosystems). miRNA comparison between the two types of 
EVs was performed on the relative expression data normalized using 
the geometric mean value of four of the most stable miRNAs identified 
in the profiling. Fold change in miRNA expression was calculated 
based on the normalized mean differences between different types of 
EVs (2−ΔCt). Since in qRT-PCR Ct scores greater than 35 are considered 
non-specific [27], miRNAs with a raw Ct value greater than 35 were not 
included in the final data analysis. Relative expression data were then 
normalized using the mean expression value, calculated on the overall 
miRNA expression in each array, according to a Ct detection cut-off of 
35 PCR cycles as described by Mestdagh et al. [23]. 
In vitro vessel-like formation assay
HMECs (30×103 cells per well) were seeded onto Matrigel-coated 
24-well plates and cultured in DMEM medium without FBS in the 
presence of 10×1010 EVs/ml. As a positive control VEGF (20 ng/ml) was 
used. After incubation for 48 h, phase-contrast images (magnification, 
×100) were recorded and the total length of the network structures was 
measured using MicroImage analysis system (Casti Imaging, Italy) 
[28]. The total length per field was calculated in five random fields and 
expressed as a ratio to the respective control.
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Figure 1: Influence of b-EVs and FGF-EVs on angiogenic properties of HMEC. A, B, C: representative images of HMEC in vitro vessel-like structure formation on 
Matrigel, (A) without stimulation (control), (B) with b-EV stimulation, or (C) with FGF-EV stimulation; D, E, F : representative in vivo vessel formation by HMEC within 
Matrigel (sections stained by trichrome method; arrows indicate red blood cell containing vessels); insert shows staining for human CD31 (green) and for mouse 
smooth muscle actin (red, white arrows); (D) non-stimulated HMEC (control); (E) HMEC stimulated with b-EVs; (F) HMEC stimulated with FGF-EVs. (G) diagram of 
number and size of in vitro formed vessel-like structures in control and in response to b-EVs or FGF-EVs stimulation (mean ± SEM, * - p<0,05 vs. “control”, ^ p<0,05 
vs. “+b-EVs”, n=15); (H) diagram of quantity and size of vessels formed within Matrigel by stimulated or non-stimulated HMEC (mean±SEM, * - p<0.05 vs. “control”, 
^ p<0.05 vs. “+b-EVs”, n=10).
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In vivo angiogenesis assay
Animal studies were conducted in accordance with the National 
Institute of Health Guide for the Care and Use of Laboratory Animals. 
The protocol was approved by the Committee on the Bioethics of the 
University of Torino (Permit Number: 1.3.10). 
Angiogenesis was assayed by measuring the growth of blood vessels 
from subcutaneous tissue into a solid gel of basement membrane. 
Firstly, HMEC (1×106 cells/injection) were incubated with b-EVs or 
FGF-EVs (1×1010 EVs/1×106 of HMEC) during 3 hours. Then, male 
severe combined immunodeficiency (SCID) mice (8 week old) were 
injected subcutaneously with 0.5 ml of ice-cold BD Matrigel Matrix 
Growth Factor Reduced (BD Biosciences, Franklin Lakes, NJ), which 
had been mixed with pre-stimulated HMEC. Equivalent quantity of 
non-stimulated HMEC was used as a negative control. The Matrigel 
plugs were excised after 10 days and fixed in 4% paraformaldehyde for 
4 h. 5–8 µm thick Matrigel-containing paraffin sections were stained 
by trichrome stain method [29]. The vessel lumen area (mean size per 
square millimeter) and quantity of erythrocyte-containing vessels were 
determined using computerized image analysis software MicroImage 
analysis system (Casti Imaging). 
Statistical analysis
Data were assessed for normality of distribution using the 
Kolmogorov-Smirnov test. Statistical analysis was performed using 
SigmaPlot 11.0 Software. Differences between treatment and control 
groups were then analysed using Student t-test when the distribution 
was normal. Data are expressed as mean ± SEM. We considered 
differences to be significant when p<0.05.
Results
bFGF does not affect EVs production by ASCs but influences 
their angiogenic potential
ASCs in basal conditions (b-EVs) produced about 10,000 ± 1,000 
EV per cell. The mean size of b-EVs was 233 ± 58 nm. These b-EVs did 
not contain DNA in detectable concentrations and therefore they were 
not represented by apoptotic bodies. ASC treatment with bFGF did not 
affect the number (10,800 ± 1,300 EV per cell), the size (245 ± 79 nm) 
of FGF-EVs or the presence of apoptotic bodies. Both, PKH26-labelled 
b-EV and FGF-EVs were internalized by HMEC within 30 minutes 
(not shown). 
b-EVs at concentration of 10×1010 EVs/ml promoted a significant 
increase of length of vessel-like structures and of the branch number in 
respect to control HMEC in a manner comparable with VEGF (20 ng/
ml) (Figures 1A and 1B). The total length and the number of branches 
of vessel-like structures formed after stimulation of HMEC with FGF-
EVs were significantly reduced in respect to b-EV stimulation and 
did not significantly differed from those of non-stimulated control 
HMEC (Figure 1C). However, FGF-EVs induced vessel-like structures 
significantly larger than those of b-EVs (Figures 1C-1G). 
HMEC treated b-EVs showed an enhanced ability to induce 
angiogenesis in vivo in respect to non-stimulated HMEC (Figures 1D-
1F). New formed vessels contained red blood cells and were positive 
for human CD31 but not for mouse smooth muscle actin. Vessels 
formed by HMEC after FGF-EV stimulation were significantly lower 
in number in respect to those formed by b-EV stimulated HMEC, but 
they were significantly larger in size and contained cells positive for 
mouse smooth muscle actin (Figure 1F-1H). 
bFGF affects protein and miRNA contents of ASC-derived 
EVs
Protein and miRNA content of FGF-EVs and b-EVs was compared. 
bFGF treatment caused down-regulation of more than 50% of analyzed 
proteins. In particular, FGF-EVs lost several angiogenic proteins, 
including APRIL, artemin, MFG-E8, MMP-20 and angiopoietin-like 
factor as well as antiangiogenic proteins including trombospondin, 
angiostatin and endostatin. At the same time 6 new angiogenesis-
modulatory proteins were found in FGF-EVs, including TRANCE and 
MMP-7.
Moreover, we compared the miRNA content of b-EVs and FGF-
EVs using microRNA assay profiling 365 mature miRNAs. b-EVs 
contained 160 miRNAs, including known pro-angio-miRs, such as 
miR-126, miR-296, miR-130a, miR-17, miR-21 and miR-210 (Table 
1). ASC treatment with bFGF caused the down-regulation of the one–
third of microRNAs detected, including 10 microRNAs, which were 
completely shut-down. The analysis revealed that in FGF-EVs the 
expression of target miRs for TRANCE (miR-125-3p, miR-194, miR-
Expressed
only in b-EVs
Expressed in b-EVs two 
times more than in FGF-
EVs
Expressed
only in FGF-EVs
hsa-miR-148a hsa-let-7a hsa-let-7c
hsa-miR-200c hsa-let-7b hsa-miR-130b
hsa-miR-222 hsa-let-7d hsa-miR-133a
hsa-miR-23a hsa-let-7e hsa-miR-184
hsa-miR-302c hsa-let-7g hsa-miR-193a-3p
hsa-miR-329 hsa-miR-100 hsa-miR-199b
hsa-miR-34c hsa-miR-101 hsa-miR-223
hsa-miR-362-3p hsa-miR-103 hsa-miR-26b
hsa-miR-542-3p hsa-miR-106a hsa-miR-27a
hsa-miR-652 hsa-miR-10a hsa-miR-28-3p
hsa-miR-10b hsa-miR-340
hsa-miR-125a-3p hsa-miR-381
hsa-miR-125b hsa-miR-483-5p
hsa-miR-127 hsa-miR-539
hsa-miR-130a hsa-miR-542-5p
hsa-miR-138 hsa-miR-545
hsa-miR-143 hsa-miR-579
hsa-miR-15b hsa-miR-654-3p
hsa-miR-17 hsa-miR-885-5p
hsa-miR-181a 
hsa-miR-185 
hsa-miR-192 
hsa-miR-193a-5p 
hsa-miR-194 
hsa-miR-195 
hsa-miR-199a 
hsa-miR-199a-3p 
hsa-miR-20a 
hsa-miR-20b 
hsa-miR-21 
hsa-miR-210 
hsa-miR-22 
hsa-miR-221 
hsa-miR-224 
hsa-miR-26a 
hsa-miR-27b 
Table 1: MicroRNA content in b-EVs and FGF-EVs.
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21, miR-224) and MMP-7 (miR-210) were down-regulated compared 
with b-EVs.
FGF-EVs modulate HMEC angiogenic properties via miRNAs 
To investigate the relevance of miRNAs in the ability of FGF-EVs 
to modulate HMEC angiogenic properties we focused on miR-21, 
a known angiomiR, and on miR-223, a known anti-angiomiR. ASC 
treatment with bFGF caused down-regulation of miR-21 more than 2 
folds and up-regulation of miR-223 up to 2.5 folds in EVs (Figure 2A). 
In contrast to EVs, the expression of miR-21 and miR-223 in ASCs only 
showed a tendency to change after bFGF treatment without reaching 
statistical significance (Figure 2B). The treatment of HMEC with b-EVs 
caused the elevation of miR-21 expression, whereas FGF-EVs enhanced 
miR-223 expression up to 3.5 folds (Figure 2С). These data indicate 
that ASCs-derived EVs modulate miRNA expression within HMEC.
To confirm the role of these two miRNAs in the ability of FGF-EVs 
to modulate HMEC angiogenic properties, we transfected HMEC with 
either mimic miR-21 or antimiR-223 or scramble RNA and 24 hrs after 
transfection the in vitro angiogenesis test was performed. Transfection 
of HMEC with mimic mi-R21 enhanced their angiogenic activity in 
spite of stimulation with FGF-EVs. Inhibition of miR-223 expression 
in HMEC restored their angiogenic potential even after FGF-EV 
addition (Figure 3A). 
Treatment with FGF-EVs changed the expression of target proteins 
for miR-21 and miR-223 in HMEC. For example, predicted targets of 
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Figure 2: Expression of miR-21 and miR-223 in EVs, ASCs and HMEC evaluated by Real-time PCR. (a) expression of miR-21 or miR-223 in b-EVs or FGF-EVs, 
(mean ± SEM, * - p<0.05 vs. “b-EVs”, n=10); (b) expression of miR-21 or miR-223 in ASCs before or after bFGF stimulation; (c) expression of miR-21 or miR-223 in 
HMEC after EV addition (mean ± SEM, * - p<0.05 vs. “HMEC”, n=10).
A
Angiogenesis in vitro
Expression of some target genes for miR21 or miR223 in
HMEC after EV addition and miR transfection
CD29, 130kD 
1,40
1,20
1,00
0,80
0,60
0,40
0,20
0,00
co
ntr
ol
+b
-EV
s
+F
GF
-EV
s
mi
m 
mi
R-
21
+F
GF
-EV
s
an
ti m
iR2
23
+F
GF
=E
Vs
Sc
rm
ble
+F
GF
-EV
s
IGFRI,  120kD 
PAX6, 46kD
GAPDH, 37kD
VEGFA, 21kD
TGFβ1, 12kD
2
1,8
1,6
1,4
1,2
1
0,8
0,6
0,4
0,2
0
re
la
tiv
e 
un
its
control +b-EVs +FGF-EVs
control +b-EVs +FGF-EVs
CD29
IFGR1
PAX6
VEGFA
TGFb1
+FGF-Evs +FGF-Evs
mimic-miR21 anti-miR223
total
length
size
B C
Figure 3: Effect of HMEC transfection with mimic miR-21 or with anti-miR-223. (a) Diagram of vessel-like structures formed in vitro by non-stimulated HMEC (control), 
by HMEC stimulated with b-EVs or FGF-EVs, or by transfected HMEC stimulated with FGF-EVs. Total length (blue column) and size (red column) of vessel-like 
structures was measured, (mean ± SEM, * - p<0,05 vs. “control total length”, ^ - p<0,05 vs. “control size”, n=15); (b) representative Western blot of proteins, that are 
targets of miR-21 or miR223; (c) expression of miR-223 or miR-21 target proteins after EV addition (data are represented as densitometric evaluation of band mean 
intensity ± SEM, * - p<0,05 vs. “+b-EVs”, n=5).
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miR-223, CD29, IGFR1 and PAX6 were down-regulated and predicted 
target of miR-21, TGFb1 was up-regulated in HMEC stimulated with 
FGF-EVs. Surprisingly, the expression of another predicted target of 
miR-21, VEGFA was down-regulated in FGF-EV stimulated HMEC 
(Figures 3B and 3C). These data suggest that EVs could regulate HMEC 
angiogenic properties through miRNAs. 
Discussion
ASCs are situated in vessel wall and play a key role in the regulation 
of angiogenesis. It has been demonstrated that these cells may either 
enhance vessel growth or inhibit vessel formation and stabilize existing 
vessels. Previous study demonstrated that EVs released by ASCs 
in basal condition or after stimulation with PDGF possessed pro-
angiogenic activity [13]. In the present study we found that bFGF may 
negatively modulate the pro-angiogenic activity of ASC-released EVs. 
This observation further supports the role of soluble factors present 
in microenvironment in the regulation of content and biological 
activities of EVs. During tissue injury or remodelling, bFGF plays a 
critical role. On one side, bFGF directly stimulates endothelial cells 
to form new vessels. On the other side, bFGF induces differentiation 
of mesenchymal stem cells (adipogenic, chondrogenic, osteogenic) 
[30,31]. Moreover, bFGF is a factor necessary for mesenchymal stem 
cell expansion and viability [31,32]. In conditions of wound healing or 
tissue repair, bFGF plays a complex action that balances angiogenesis 
with vessel stabilization and maturation. Here we found that addition 
of bFGF in culture stimulates ASCs to secrete EVs with a reduced 
angiogenic potential that may favour stabilisation of vessel growth. 
These functional changes were paralleled by an altered protein and 
miRNA composition of EVs. In particular we found a down-regulation 
of the pro-angiogenic miR-21 and down-regulation of anti-angiogenic 
miR-223. The role of miR21 in angiogenesis is not univocal and 
depends from target cells and cell environment. In fact, miR21 has 
been shown to stimulate [33] or suppress [34] angiogenesis through 
different pathways. MiR-223 is an anti-angiomiR. Overexpression of 
pre-miR-223 was shown to inhibit endothelial cell migration, tube 
formation on Matrigel and to prevent sprouting in a modified spheroid 
assay [35]. MiR-223 has been shown to target beta-1 integrin and to 
prevent bFGF-induced migration and sprouting of endothelial cells 
[35]. We observed that HMEC transfection with mimic miR-21 or 
antagomiR-223 abrogated the effect of FGF-EVs, suggesting the critical 
role of these two miRs in the biological activity of ASC-derived EVs. 
Inhibitory function of FGF-EVs on angiogenesis may account for 
the role of ASC in stabilising existing vessels. 
Conclusion
In conclusion, these results indicate that the content and 
functions of EVs produced from ASCs are modulated by a soluble 
factor, such as bFGF. Therefore, culture conditions may change the 
composition and the biological activities of EVs produced by ASCs. 
This has an implication for eventual production of EVs for therapeutic 
purposes in case of pathological angiogenesis, such as in tumors, 
chronic inflammatory disorders, diabetic retinopathy where the 
pro-angiogenic properties of EVs are unwanted. Understanding of 
molecular mechanisms of bFGF actions on EV secretion is important 
for the therapeutic use of this factor.
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